A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence
Abstract Monoacylglycerol lipase (MAGL) regulates endocannabinoid 2-arachidonoylglycerol (2-AG) and eicosanoid signalling. MAGL inhibition provides therapeutic opportunities but clinical potential is…